The Interface Playbook · The Wrist Play
The Interface
The Apple Watch shipped in April 2015 and has paired with exactly one thing since: an iPhone. No Android phone has ever set one up [D]. That one rule turns a watch into a gravity well—every Watch on a wrist makes its owner's next phone an iPhone. The Justice Department's 2024 antitrust complaint treats the design exactly that way: not an accessory, a switching cost.
The Ledger
Ten years in, Apple still ships more smartwatches than anyone on earth—first place every year since launch. Now read the right edge of the chart plainly: shipments peaked in 2022, fell in 2023, then dropped another 19% in 2024 as Apple's share slid from 25% to 22% [R, Counterpoint]. The market itself shrank for the first time ever, and China displaced North America as its largest region. No competitor took the wrist. The wrist just stopped upgrading.
The Health Land-Grab
The strategy that outlasts a slow market: turn the watch from accessory into instrument. ECG and irregular-rhythm notifications cleared the FDA in September 2018—the first over-the-counter ECG of its kind. AFib History followed in 2022, sleep-apnea notifications in September 2024, and hypertension notifications in September 2025, a feature Apple expects to flag more than a million undiagnosed people in its first year [R]. Each stair took studies, submissions, and years. Each is a climb a rival must repeat from the bottom. And the one sensor Apple shipped without asking the FDA, blood oxygen in 2020, is the one that ended up in court.
The Sensor War
No rival watch ever took a feature off Apple's wrist. A medical-device company did. Masimo sued in January 2020; by Christmas 2023 the ITC had banned Apple Watch imports over the blood-oxygen sensor, and Apple stripped the feature from every US model it sold from January 2024. The workaround, shipped August 2025, is the playbook in miniature: the sensor stays on the wrist, the computation moves to the paired iPhone. Then November 2025: a federal jury ordered Apple to pay $634 million. Apple is appealing—but the scoreboard now shows one loss, and no competitor is on it.
The Comparison
Measure in units and it is a rout: roughly 31 million Apple Watches shipped in 2024 [E] against the 15.3 million watches exported by the entire Swiss industry [D]—one product out-shipping a nation's signature craft two to one. Measure in money and the picture flips: Swiss exports earned about $29 billion; Apple Watch revenue is a number Apple has never disclosed, folded into a $35.7 billion segment with AirPods and HomePods. Reporting pegs the Watch near $17–20 billion [R]. The Swiss, for now, still out-earn the watch that out-ships them.
The Tell
Score the decade. Broken by a rival watch: no—Samsung, Google, and Garmin never knocked it from first place. Dented: yes, twice, by a market that stopped upgrading and by the only courtroom that ever stripped a feature off the wrist. The scoreboard itself stays dark; Apple has never published a single Watch unit or revenue figure. Three numbers decide the next chapter: whether 22% share holds, how far the hypertension alert reaches, and what survives of the $634 million on appeal.
End of the play
Plays explored: 1 of 14